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New Findings Section 
What is the central question of this study?  
Although peripheral blood HPCs are potentially important in regeneration after acute myocardial 
infarction (MI), their self-renewal ability in the post-acute phase has not yet been addressed.  
What is the main finding and its importance?  
In rat peripheral blood, we show that MI does not negatively affect circulating HPC self-renewal 
ability two weeks after acute infarction which suggests a constant regenerative potential in the MI 
post-acute phase.  
 
Abstract 
Due to the importance of peripheral blood hematopoietic stem and progenitor cells (HPCs) in post-
acute regeneration after acute myocardial infarction (MI), the present study aimed to investigate count 
and secondary replating capacity/self-renewal ability of HPCs in peripheral blood before and two 
weeks after MI. In nine female Lewis inbred rats (n=9), myocardial infarction was induced by ligation 
of the left coronary artery while another nine had surgery without ligation for control purposes. 
Myocardial infarction was confirmed by troponin I concentrations 24h after MI. Peripheral blood was 
withdrawn and fractional shortening (FS) and ejection fraction (EF) of the left ventricle was assessed 
before (day-0) and 14 days after MI or control surgery (day-14). After mononuclear cell isolation, 
primary/secondary functional colony-forming unit-granulocyte macrophage (CFU-GM) assays were 
performed in order to detect the kinetics of functional HPC colony count and cell self-renewal ability 
in vitro. CFU-GM count and cell self-renewal ability remained unchanged (p>0.05) in both groups at 
day-14 without interaction between groups. In the intervention group, higher day-0 CFU-GM counts 
showed a relation to lower FS on day-14 (=-0.82; p<0.01). Myocardial infarction did not negatively 
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affect circulating HPC self-renewal ability, which suggests a constant regenerative potential in the 
post-acute phase. A relation of cardiac contractile function 14 days after MI with circulating CFU-GM 
count on day-0 might imply functional colony count as a predictive factor for outcome after 
infarction.  
 
Introduction 
Acute myocardial infarction (MI) is characterized by a generalized inflammatory reaction triggering 
the rapid mobilization of stem and progenitor cells from bone-marrow (BM), which are important for 
acute and post-acute regeneration processes. The contribution of circulating cells to myocardial repair, 
however, is not yet fully understood, although experimental studies have seen the potential in bone-
marrow derived precursor cells for cardiac regeneration after MI(Wojakowski et al., 2012). The 
possible therapeutic effect of circulating hematopoietic stem and progenitor cells (HPCs) on damaged 
heart tissue is currently the subject of intense debate(Anversa et al., 2013). The current predominant 
view is that these cells secrete a variety of cytokines that activate endogenous progenitors in the heart 
muscle, which are responsible for the repair process and the improvement in e.g. ventricular 
function(Anversa et al., 2013). Therefore the body’s own regenerative ability (to counteract 
pathological heart remodeling and improve ejection fraction/systolic function) depends, among others, 
on the circulating number and  secondary replating capacity/self-renewal ability of these cells after the 
infarction. Although some human as well as animal studies have documented the kinetics of HPC in 
the first week after infarction(Paczkowska et al., 2005; Assmus et al., 2012; Wojakowski et al., 
2012), the post-acute phase (e.g. 14 days after MI) has had little attention so far while long-term 
outcomes mainly assessed endothelial progenitor cell kinetics(Regueiro et al., 2015). Acute 
myocardial infarction was shown to increase the number of immune cells(Tsujioka et al., 2009; 
Gentek & Hoeffel, 2017), BM(Assmus et al., 2012) and peripheral blood (PB)(Leone et al., 2005; 
Assmus et al., 2012) HPCs one week after MI with BM functional HPC colony number being 
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elevated after MI, possibly due to an increased BM activity. Peripheral blood HPCs stayed elevated 
two weeks after MI in a rat model(Abdelmonem et al., 2015), but the self-renewal ability of PB HPCs 
was not assessed, although this would provide important information regarding self-regeneration 
during this post-acute phase. In addition, controversy exists as to whether the initial increase in HPC 
number would have declined towards baseline by day-14 as extrapolated from literature 
results(Shintani et al., 2001). Therefore, the aim of the present study was to investigate i) the 
functional colony count and self-renewal ability of circulating HPCs in the peripheral blood and their 
association with heart function and ii) the MI-induced change of risk-associated blood cell counts, e.g. 
neutrophil-to-lymphocyte ratio, in a rat model.  
 
Methods 
Ethical approval 
All animals received care in compliance with the European Convention on Animal Care. The surgical 
procedures were performed in accordance with the Swiss Animal Protection Law after obtaining 
permission from the State Veterinary Office, Fribourg, and approval from the Swiss Federal 
Veterinary Office, Switzerland (Ethics approval number: 2013_09E_FR). All procedures used 
conform to the principles and regulations as described by given guidelines(Grundy, 2015). 
Animals, invasive procedures and post-operative care  
Eighteen female LEWIS inbred rats (weight=215.211.3g; from Janvier, France) were divided into an 
intervention group (IG, n=9) and a control group (CG, n=9). Food (normal diet/pellets) and fresh 
water was provided ad libitum. One rat of the CG unexpectedly died before day-14.  
As previously described(Frobert et al., 2014), animals were placed in an induction chamber with 5% 
isoflurane in oxygen for 5-7 min. A toe and tail pinch confirmed sedation. Animals were then placed 
on a warming pad at 37°C and intubated. Anesthesia was sustained with 2.5% isoflurane in oxygen at 
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a minute ventilation of 2.5 L/min. Depth of anesthesia was continuously monitored by assessment of 
tail-pinch reflex and respiratory rhythm. Following a left thoracotomy between the fourth and fifth 
interstitial space, the pericardium was opened to access the heart and the left anterior descending 
coronary artery (LAD) was ligated only for animals of the IG, while animals of the CG were closed 
without ligation. The investigators took all possible steps to minimize animals’ pain and suffering. 
One third of the dose of buprenorphine (0.1 mg/kg) was injected subcutaneously 20-30 min before the 
beginning of the anesthesia and two third immediately before the end of the surgery as post-operative 
analgesia. A second dose was administered 6h after surgery and buprenorphine was added to the 
water during the night. Further doses were administered after 24h and 48h with supplementation of 
the water with buprenorphine during the night. Between 24 and 48h, further doses of analgesics were 
administered depending on the score during post-operative pain evaluation. Welfare monitoring of 
animals via behavioral observation was performed every day. After surgery, the animals were kept 
separately in a cage warmed with a heat lamp until they had fully recovered from anesthesia. They 
were then put back together, 5 rats per cage (1800 cm
2
), according to the Eurostandard type III. Food 
(pellets) and fresh water was provided ad libitum. A 12h:12h light:dark cycle and a constant 
temperature of 24°C were maintained during the entire experimentation time. Blood sampling was 
performed under general anesthesia maintained with 2.5% isoflurane in 2.5L/min oxygen with a face 
mask. At the end of the study, animals were humanely killed. Exsanguination was performed under 
general anesthesia (isoflurane 2.5% in 2.5L/min oxygen), the thorax was opened, blood withdrawn 
from the vena cava and the heart harvested.  
To verify infarct development (IG only), a blood sample was collected from the caudal tail artery at 
24h post LAD ligation. Plasma was stored at 80°C. Troponin I quantification was performed as 
previously described(Frobert et al., 2015) using the AccuTNI3+ immunoassay. Heart function was 
assessed under light anesthesia (2% isoflurane) using a Vevo3100 (Visualsonic) high-resolution 
ultrasound imaging system. Pre-MI (day-0), 24h (day-1), 1 week (day-7) and 2 weeks (day-14) post 
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MI, the ejection fraction (EF) was determined in B-Mode and the fractional shortening (FS) in M-
Mode on a parasternal long axis view.  
Mononuclear cell isolation 
At baseline and 14 days after MI induction or control surgery, peripheral blood was withdrawn from 
the caudal vein (700-1000µL) into lithium-heparinized tubes of which 100µl of whole blood was kept 
for hematological analysis and the remaining volume was subjected to a standard Ficoll gradient 
centrifugation (Histopaque; Sigma-Aldrich) according to the manufacturer’s instruction in order to 
isolate peripheral blood mononuclear cells for hematopoietic stem and progenitor cell functionality 
tests such as functional colony number and secondary replating capacity/self-renewal ability (primary, 
secondary colony-forming unit assays respectively). 
Analysis of blood cell counts 
Blood cell counts were analyzed at baseline (day-0) and 14 days after MI or control surgery (day-14) 
using 100µL of whole blood. Analysis was performed with a general rat program of a hematology 
analyzer (dilution 1:3, 1:6 or 1:12, ADVIA 2120i, Siemens, Zurich, Switzerland). Lithium-heparin 
anti-coagulated blood has some limitations for blood cell analysis (e.g. platelet clumping(Guzman et 
al., 2008)), which was taken into account for the presentation of final results.  
Primary/Secondary colony-forming unit assays  
Primary and secondary hematopoietic colony-forming unit granulocyte, macrophage (CFU-GM) 
assays were performed as published(Stelzer et al., 2010) with slight modification of the procedure for 
peripheral blood. Peripheral blood mononuclear cells were plated at a concentration of 200’000 
cells/mL in methylcellulose culture medium for rats (Methocult GF R3774; StemCell Technologies, 
Vancouver, Canada) in 12-well flat-bottom plates and incubated at 37°C (5% CO2, >95% humidity). 
On the 6
th
 day of incubation, colonies consisting of at least 50 cells were scored providing the number 
of functional hematopoietic progenitor cells (primary CFU-GM) of each animal. Colonies were 
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counted and up to 60 primary CFU-GM colonies were individually plucked from the methylcellulose 
culture medium and transferred to individual wells of a 48-well flat-bottom plate and thoroughly 
mixed with methylcellulose culture medium to get a single-cell suspension. After another 8 days of 
incubation, each well was scored for the number of CFU-GM colonies consisting of more than 50 
cells (secondary CFU-GM). The secondary replating capacity is known to be associated with the 
proliferative capacity of myeloid progenitor cells(Gordon et al., 1998; Withey et al., 2005). The 
original protocol for human cells was modified for rat peripheral blood by transferring fewer colonies 
(up to 60 instead of 90), since rat cells have a higher CFU-GM replating efficiency than human cells 
with respect to the number of clonogenic primary colonies and the produced number of secondary 
colonies per primary replated CFU-GM(Alenzi et al., 2002). 
Analysis of secondary CFU-GM assays 
For analysis of secondary CFU-GM assays, the number of secondary CFU-GM produced by each 
primary CFU-GM was used as raw data. Counts exceeding 100 were truncated. The secondary 
replating capacity of an individual was defined to be the mean of the log 2 of the number of colonies 
plus one for the following reasons: The log 2 scale is natural, as the distribution of number of 
secondary colony-forming cells is skewed to the right. One was added, as the log 2 of 0 cannot be 
calculated and the log 2 of this number is a continuous measure of the number of duplications of a 
primary CFU-GM. This measure has similar properties as the measure used by Gordon et al. 
(1998)(Gordon et al., 1998) as counts of zero are adequately taken into account and the log scale 
reduces skewness. 
Statistics 
Data are represented as mean ± standard deviation (SD) unless otherwise stated. A-priori power 
analysis (paired t-test) was used to calculate the necessary sample size. Based on published 
differences(Paczkowska et al., 2005; Assmus et al., 2012; Wojakowski et al., 2012) in CFU-GM 
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bone-marrow colony number before (4515) and 7 days after MI (6918) in mice, an alpha error of 
0.05, a 1-beta error of 0.8, and an effect size of 1.437, a sample size of n=6 was determined. To 
consider possible drop-outs, a total sample size of n=9 was chosen. A two-way ANOVA was carried 
out in order to compare the time effects between day-0 and day-14 and possible interactions among 
groups. Post-hoc tests were performed when appropriate. Pearson’s correlation analysis was used to 
determine the relationship between variables.  
 
Results 
Confirmation of infarction 
Cardiac troponin I (cTnI) was significantly increased 24h after MI (26.01±6.08 ng/mL) in the IG. 
Fractional shortening and EF were significantly reduced already after 24h and stayed low until 2 
weeks post MI (Fig 1A, B). 
 
Progenitor cell number and secondary replating capacity/self-renewal ability 
At baseline, groups were comparable (p>0.05) regarding both CFU-GM number and cell self-renewal 
ability. Two weeks after MI, on day-14, both CFU-GM number and HPCs’ self-renewal ability did 
not differ from respective baseline values (p>0.05, Fig 2A, B). There was no statistical interaction 
between groups (p>0.05). Also, individual changes in CFU-GM number were not related to respective 
changes in self-renewal ability. In the IG, CFU-GM number on day-0 and FS on day-14 were 
significantly associated (=-0.82; p<0.01, Fig 3). Cell self-renewal ability on day-0 was not associated 
with cardiac function on day-14 (p>0.05).  
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Blood cell counts  
Time effects for blood cell counts (Table 1) of the IG showed significant increases of mean 
corpuscular volume (MCV, p<0.001), monocytes (MONO, p<0.05), neutrophils (NEU, p<0.01), 
basophiles (BASO, p<0.05) as well as percent lymphocytes (percLYM, p<0.01), monocytes 
(percMONO, p<0.05), neutrophils (percNEU, p<0.01), basophiles (percBASO, p<0.05) and 
neutrophil/lymphocyte (NL) ratio (p<0.01) two weeks after MI. In the CG only MONO, and 
percMONO (both p<0.01) were significantly elevated at day-14 after surgery. Only percLYM, 
percNEU and NL ratio showed a significant interaction between groups (p<0.05).  
Posthoc tests between groups revealed that the CG and the IG were comparable at baseline for all 
variables, except for the IG having higher percNEU values (both p<0.01). At day-14 the groups 
differed in percNEU, percLYM (both p<0.05) and also NL ratio (p<0.05) with percNEU and NL ratio 
being higher and percLYM lower in the IG.  
Day-0 FS was significantly correlated with day-0 MCV (r=-0.709, p<0.05), while day-14 FS 
correlated significantly with percMONO (r=0.738, p<0.05).  
Discussion 
This study investigated the regenerative potential of circulating HPCs in the post-acute phase after MI 
in a rat model. Interestingly, no significant change in mean functional progenitor cell number (CFU-
GM count) and cells’ self-renewal ability was present in the IG nor the CG 14 days after induction of 
MI or control surgery, although ejection fraction and fractional shortening were significantly reduced 
(Fig 1A, B; Fig 2A, B) in the IG. 
Our results extend the current knowledge as we assessed the functional count of HPCs as CFU-GM in 
cell culture rather than CD34+ cell number. Wojakowski et al. (2004), for example, reported 
circulating CD34+ cell number being elevated one week after MI in comparison to healthy control 
subjects(Wojakowski et al., 2004). A similar finding was reported in a rat model with induced MI 
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where CD34+ cell number one week after MI was compared to baseline prior to MI(Lehrke et al., 
2006). It was also shown that CD34+ cell count was highest 7 days after MI in humans and was lower 
on day 14, reaching values comparable to the control group(Shintani et al., 2001). This is consistent 
with our results in the rat model. In addition, literature states that circulating progenitor cells should 
be back to baseline levels already 24h after an operative procedure(Choi et al., 2010).  
We also showed that the HPCs’ self-renewal ability in the post-acute phase after MI on average was 
not reduced compared to baseline and showed the same behavior as in the CG. Our results therefore 
imply that HPCs circulating in the post-acute phase after MI are still as functionally competent as 
before MI and still have the potency to form colonies. Unfortunately, previous studies reporting 
increased BM and PB HPCs/CFU-GMs up to one or two weeks(Leone et al., 2005; Assmus et al., 
2012; Abdelmonem et al., 2015) after MI, did not investigate the self-renewal ability of PB HPCs, 
such that our results cannot be compared to these(Xin et al., 2008).  
Looking at Fig 2B more in detail, it is visible that three animals of the IG showed an increased self-
renewal ability, while the other six animals had constant to decreasing values. This is an interesting 
observation, since these three could resemble the picture of progenitor mobilization associated with a 
higher ex-vivo expansion of CD34+ cells(Ivanovic et al., 2010) after MI showing survival of only the 
“fittest” progenitor cells with the highest self-renewal ability.  
The presence of an on average constant regenerative potential of HPCs in the post-acute phase 
supports the body’s active self-regenerative potential although the IG in comparison to the CG 
showed signs of MI-induced inflammation such as increased percNEU- associated with increased 
long-term mortality in acute MI patients(Gentek & Hoeffel, 2017)- and NL ratio(Caimi et al., 2016) 
two weeks after MI onset. The decreased percLYM at day-14 in the IG might be due to the post-
infarction cardiac impairment that triggered important autonomic reflexes (e.g. sympathetic overdrive) 
and could also impact lymphocytes’ physiology in a nonclassical fashion(Nunes-Silva et al., 2017). 
Within groups, the significant increase in mature neutrophil and monocyte numbers, but unchanged 
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differentiation of immature HPC (CFU-GM number) could imply disease(Gentek & Hoeffel, 2017) or 
non-disease(Selig & Nothdurft, 1995) related inflammation. Furthermore, it is important to consider 
that an automatic hematology analysis system, such as ADVIA 2120i, only distinguishes monocytes 
and neutrophils according to their morphology- e.g. levels of peroxidase activity(Canovi & Campioli, 
2016)- but not based on their functionality. Immature cells being functionally competent to form 
colonies under in vitro conditions might not show the same dynamics as the different mature myeloid 
subgroups or total white blood cell counts found with flow cytometry.  
Day-0 functional CFU-GM count was negatively correlated with FS 14 days after MI (Fig 3), which 
might indicate a predictive potential of the baseline colony number for the contractile function in the 
post-acute phase after MI. A higher number of angiogenic colony forming units (CFU-A) was already 
found to be significantly associated with cardiovascular disease risk(Mavromatis et al., 2012), but no 
study has yet reported the possible prediction of MI outcome by pre MI CFU-GM colony number. 
Results of our study extend these findings of Mavromatis et al. (2012), where a higher circulating 
proangiogenic cell activity by CFU-A was associated with worse clinical outcome in those with CVD. 
Functional CFU-GM count of circulating HPCs can be suggested to have a predictive potential in a 
pre-diseased state, as it had already been suggested for CD34+ count and the prediction of future 
metabolic deterioration in healthy individuals(Fadini et al., 2015). This would mean that constant 
tissue-regeneration and substitution in the healthy come along with a comparatively low circulating 
CFU-GM number and a “better” outcome after a deteriorating cardiovascular incidence such as MI. 
Interestingly- besides significantly increased cTnI concentrations 24h after LAD ligation- our high-
resolution ultrasound imaging system showed a significant reduction of the heart function parameters 
FS (M-mode) and EF (B-mode) already. Cardiac troponin I levels provide an excellent quality control 
of infarct size and may be used as a prognostic marker(Frobert et al., 2015). High-resolution 
microimaging has already been shown to be a useful method for the accurate assessment of cardiac 
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function in mice(Okajima et al., 2007) and with this study was first proved to be adaptable to a rat 
model. The drop in heart function for FS and EF remained low until day-14 post MI. 
In our study FS was related to percMONO on day-14. Distinct MONO subsets have already been 
suggested to predict cardiovascular events in heart-disease patients(Rogacev et al., 2012), but the 
relationship between MONO and cardiac function two weeks post MI has not yet been found.  
Our result could indicate that the relative amount of circulating monocytes is a possible indicator for 
cardiac contractile function. 
In conclusion, myocardial infarction did not negatively affect circulating HPC self-renewal ability on 
day-14 after MI, which suggests a constant regenerative potential in the post-acute phase after MI. 
Possibly, day-0 circulating CFU-GM count might have the potential to predict outcome after 
infarction which would stress the importance of interventions able to support life-long regeneration in 
the (still) healthy such as regular physical exercise.  
 
Limitations 
One limitation could be seen in the baseline difference of perNEU counts. This difference might be 
due to IG and CG being from the same brand of rats but coming from different litters. To minimize 
bias, the same animals were used at baseline and after two weeks. Therefore, peripheral blood was 
investigated instead of bone marrow. Ideally cell proliferation would have been measured by Ki-67/PI 
staining(Kim & Sederstrom, 2015) using flow cytometry in parallel to the cell culture experiment. 
This, however, was not possible due to the limited sample material available.  
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Values are means ± SD. WBC, white blood cell count; RBC, red blood cell count; Hct, hematocrit; Hgb, hemoglobin; 
MCV, mean corpuscular volume; NL ratio, neutrophil-to-lymphocyte ratio; Significant differences between time 
points are indicated as: ***p < 0.001, **p < 0.01, *p < 0.05; significant differences to the intervention group for the same 
time points are indicated as: 
††
p < 0.01, 
†
p < 0.05 
Table 1 CONTROL GROUP INTERVENTION GROUP 
Blood 
Collection 
Day-0 Day-14 
post MI 
N Day-0 Day-14 
post MI 
N 
WBC, 10
9
/L 7.90  1.55 9.91  
4.05 
6 8.72  1.12 10.37  
1.59 
9 
RBC, 10
12
/L 8.1  0.9 7.9  
1.3 
6 8.2  0.6 7.5  
2.0 
8 
Hct, % 39  5 39  7 6 41  4 39  10 8 
Hgb, g/dL 15.8  1.6 24.9  
26.0 
6 15.7  1.7 14.9  
4.6 
8 
MCV, fL 50.8  2.5 50.6  
1.1 
6 49.5  1.3 52.3  
0.9*** 
9 
Lymphocytes, 
10
3
/µl 
6.58  1.94 7.98  
2.76 
6 7.41  0.94 7.26  
1.02 
9 
Monocytes, 
10
3
/µl 
0.09  0.07 0.26  
0.13** 
6 0.09  0.03 0.19  
0.12* 
9 
Neutrophils, 
10
3
/µl 
0.78  0.19 1.6  
1.4 
6 1.1  0.2 2.8  
1.2** 
9 
Basophils, 
10
3
/µl 
0.02  0.02 0.080  
0.102 
6 0.003  0.010 0.04  
0.03* 
9 
Lymphocytes, 
% 
86.1  0.9 82.4  
8.2† 
6 85.1  1.3 70.7  
9.7** 
9 
Monocytes, % 1.2  0.7 2.4  
0.7** 
6 1.1  0.3 1.8  
1.0* 
9 
Neutrophils, % 10.6  1.2†† 13.8  
7.3† 
6 12.9  1.1 26.4  
8.7** 
9 
Basophils, % 0.32  0.17 0.63  
0.64 
6 0.14  0.07 0.39  
0.21* 
9 
NL ratio 0.126  0.048 0.177  
0.122† 
6 0.151  0.014 0.396  
0.191** 
9 
  
 
This article is protected by copyright. All rights reserved. 
 
 
Figure Legends 
 
Fig 1: Fractional shortening (A) and ejection fraction (B) at baseline (day-0), 24h  
(day-1), one week (day-7) and two weeks (day-14) after induction of acute myocardial infarction (MI) 
in rats (n=9, mean±SD). It is clearly visible that both parameters show a highly significant decrease 
already after one day indicating a huge impairment of systolic heart function due to MI. 
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Fig 2: Colony-forming unit granulocyte macrophage (CFU-GM) count per totally plated mononuclear 
cells (MNC) (A) and HPC’s self-renewal ability (B) at baseline (day-0) and two weeks (day-14) after 
acute myocardial infarction (MI). Parameters did not show any significant change at day-14 nor 
interaction between groups, which suggests a constant regenerative potential in the post-acute phase 
after MI. 
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Fig 3: Colony-forming unit granulocyte macrophage (CFU-GM) number at baseline (day-0) and 
fractional shortening (FS) at two weeks (day-14) post-acute myocardial infarction (MI) were 
negatively correlated (n=9), which might indicate a predictive potential of baseline colony number for 
contractile function in the post-acute phase after MI. 
 
